FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $2.5B
1-Year Est. Return 52.94%
This Quarter Est. Return
1 Year Est. Return
+52.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.38B
AUM Growth
-$227M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
52
New
Increased
Reduced
Closed

Top Buys

1
+$19.4M
2
+$18.5M
3
+$18.2M
4
MGNX icon
MacroGenics
MGNX
+$12.2M
5
MORF
Morphic Holding, Inc. Common Stock
MORF
+$8.06M

Top Sells

1
+$143M
2
+$16.4M
3
+$4.35M
4
REPL icon
Replimune Group
REPL
+$4.32M
5
EPIX
ESSA Pharma
EPIX
+$1.52M

Sector Composition

1 Healthcare 99.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$162M 11.71%
9,781,472
+23,113
2
$126M 9.09%
9,341,551
3
$101M 7.28%
4,345,559
4
$95.5M 6.92%
8,684,232
5
$92.7M 6.71%
3,860,107
6
$78.3M 5.67%
3,708,838
7
$75.7M 5.48%
945,407
-54,330
8
$60M 4.35%
8,407,152
9
$59.1M 4.28%
2,944,349
+128,629
10
$52.4M 3.79%
1,397,405
11
$38.6M 2.8%
2,164,739
+270,739
12
$25.5M 1.84%
3,238,859
13
$23.3M 1.69%
2,159,154
+50,000
14
$23.1M 1.67%
2,985,757
15
$22.8M 1.65%
1,421,310
+93,645
16
$22.7M 1.65%
1,414,823
17
$22.5M 1.63%
1,787,527
18
$20M 1.45%
2,248,194
+850,000
19
$19.6M 1.42%
899,700
20
$19.4M 1.41%
+1,171,650
21
$18.5M 1.34%
+854,484
22
$18.2M 1.32%
+830,983
23
$16.1M 1.17%
857,338
24
$14.4M 1.04%
5,162,348
25
$13.7M 0.99%
746,479
1
2 3